Treatment Efficacy
Beta-blocker bisoprolol fails to lower COPD exacerbations in patients at high risk
SAN DIEGO — Bisoprolol treatment yielded a similar yearly rate of COPD exacerbations that require oral corticosteroids and/or antibiotics to placebo, according to research presented at the American Thoracic Society International Conference.
MiDROPS demonstrates safety, efficacy in phase 2 clinical trial
EyeCRO announced that its Microemulsion Drug Ocular Penetration System, or MiDROPS, demonstrated safety and efficacy in its first clinical application as a topical eye drop vehicle for dry eye disease.
Breathomics, plasma lipidomics predict responses to omalizumab in asthma
Among patients with severe asthma receiving omalizumab, breathomics and plasma lipidomics predicted early and late treatment responses, according to results published in American Journal of Respiratory and Critical Care Medicine.
VIDEO: Gene therapy requires a delicate balance between efficacy and safety
In this Healio Video Perspective from the FLORetina-ICOOR meeting, Suber S. Huang, MD, MBA, speaks about adverse events in gene therapy.
Treatment weeks 17 to 62 most effective for azithromycin in children with bronchiectasis
Children with bronchiectasis taking azithromycin had the greatest benefits from weeks 17 to 62 out of 105 weeks of treatment, according to study results published in CHEST.
Shorter TB regimen noninferior to standard 24-week treatment, study finds
SEATTLE — An 8-week boosted regimen of bedaquiline and linezolid was noninferior to standard 24-week treatment for tuberculosis in terms of clinical outcomes, according to the results of a phase 2-3 trial.
APA releases new guidelines for assessment, treatment of eating disorders
The American Psychiatric Association plans to align treatment of eating disorders with a focus on risk-benefit analysis of physical and psychosocial factors, according to new guidelines published in the American Journal of Psychiatry.
Cefepime-taniborbactam statistically superior to meropenem for treatment of cUTI
WASHINGTON — Cefepime-taniborbactam was statistically superior to meropenem for the treatment of complicated UTIs, including acute pyelonephritis, according to data presented at IDWeek.
Patients with CDI given ridinilazole had sustained clinical response, fewer recurrences
WASHINGTON — Nearly three out of every four patients with Clostridioides difficile infection being treated with ridinilazole had a sustained clinical response, according to data presented at IDWeek.
Cefiderocol effective against treatment-resistant bacteria, studies find
WASHINGTON — Several studies showcase strong efficacy of cefiderocol against treatment-resistant Pseudomonas aeruginosa and Acinetobacter baumannii both in the U.S. and abroad, according to data presented at IDWeek.